Mostrar registro simples

dc.contributor.authorSchlickmann, Thomas Hugentoblerpt_BR
dc.contributor.authorTessari, Marcelo Sommapt_BR
dc.contributor.authorBorelli, Wyllians José Vendraminipt_BR
dc.contributor.authorMarconi, Gabriel Alvespt_BR
dc.contributor.authorPereira, Gabriela Magalhãespt_BR
dc.contributor.authorZimmer, Eduardo Boeckpt_BR
dc.contributor.authorNoyce, Alastair Johnpt_BR
dc.contributor.authorMata, Ignacio Fernandezpt_BR
dc.contributor.authorRieder, Carlos Roberto de Mellopt_BR
dc.contributor.authorSantos, Daniel Teixeira dospt_BR
dc.contributor.authorSchuh, Artur Francisco Schumacherpt_BR
dc.date.accessioned2025-05-09T06:43:41Zpt_BR
dc.date.issued2025pt_BR
dc.identifier.issn2667-193Xpt_BR
dc.identifier.urihttp://hdl.handle.net/10183/291410pt_BR
dc.description.abstractBackground There is limited epidemiological data regarding Parkinson's disease (PD) prevalence in Brazil, which hinders adequate public health policies planning and patient care. This study aimed to investigate the distribution, prevalence, and clinical characteristics of PD among older adults in Brazil. Methods This cross-sectional study used data from the ELSI-Brazil cohort, a Brazilian nationally representative study of individuals aged 50 and older. Data were collected through door-to-door surveys with standardized questionnaires. PD diagnosis was based on self-reported data. We calculated PD prevalence in the general population and specific age groups, studied its association with clinical variables, and projected PD prevalence in Brazil from 2024 to 2060. Findings A total of 9881 respondents were included in this study, and 93 reported a medical diagnosis of PD. The crude prevalence of PD among Brazilians aged 50 or more was 0.84% (95% CI: 0.64%–1.09%), with an age- and sex-standardized prevalence of 0.86% (95% CI: 0.62%–1.10%). Men were more affected than women (OR: 2.35, 95% CI: 1.35–4.08; p < 0.01), and the prevalence was higher in older age groups, from 0.39% in those aged 50–59 years to 2.75% in those 80 years and older. PD individuals had higher rates of stroke, depression, functional dependency, and were more likely to need walking support or be bedridden. Projections indicated that PD cases in Brazil will rise from 535,999 (95% CI: 309,963–922,948) in 2024 to 1,250,638 (95% CI: 734,660–2,117,585) by 2060. Interpretation This study reveals the prevalence and distribution of PD in Brazil, showing many patients with advanced disease and suggesting underdiagnosis in early stages. There is a need for better diagnostic accuracy, improved access to neurologists, and comprehensive public health strategies to manage the rising prevalence and healthcare demands of PD in Brazil.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofThe Lancet regional health : Americas. Oxford. Vol. 44 (Apr. 2025), 101046, 10 p.pt_BR
dc.rightsOpen Accessen
dc.subjectDoença de Parkinsonpt_BR
dc.subjectParkinson’s diseaseen
dc.subjectPrevalênciapt_BR
dc.subjectMovement disordersen
dc.subjectEpidemiologyen
dc.subjectTranstornos dos movimentospt_BR
dc.subjectBrasilpt_BR
dc.subjectPrevalenceen
dc.subjectNeurodegenerative diseasesen
dc.titlePrevalence, distribution and future projections of Parkinson disease in Brazil : insights from the ELSI-Brazil cohort studypt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001248879pt_BR
dc.type.originEstrangeiropt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples